| Laura Cohon Shaikh, MD | |
|
77 N Airlite St, Elgin, IL 60123-4912 | |
| (847) 289-5727 | |
| (847) 888-5469 |
| Full Name | Laura Cohon Shaikh |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 18 Years |
| Location | 77 N Airlite St, Elgin, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801119730 | NPI | - | NPPES |
| 002571140 | Other | PA | HIGHMARK BLUE SHIELD |
| 30148041 | Other | PA | AMERIHEALTH CARISTAS |
| 9606680 | Other | PA | AETNA |
| 1801119730 | Other | PA | UNITED HEALTH CARE |
| 036.124875 | Other | IL | STATE LICENSE |
| 102786865-0001 | Medicaid | PA | |
| 1801119730 | Other | PA | GEISINGER HEALTH PLAN |
| 1027868650001 | Other | PA | COVENTRY |
| 8234481 | Other | PA | CIGNA/GREATWEST HEALTHCARE |
| 830726 | Other | PA | FPH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Swedish Covenant Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Rehabilitation Care Llc | 8628253259 | 17 |
News Archive
While depression appears to be common in early Parkinson's disease (PD), it is often not treated or diagnosed, according to newly released research.
New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic.
Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study. Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company's proprietary PHOENIX System that combines the intramyocardial delivery of stem cells with transmyocardial revascularization (TMR).
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.
› Verified 5 days ago
| Entity Name | Lynn Mershon Do Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215954185 PECOS PAC ID: 4385537299 Enrollment ID: O20040204001001 |
News Archive
While depression appears to be common in early Parkinson's disease (PD), it is often not treated or diagnosed, according to newly released research.
New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic.
Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study. Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company's proprietary PHOENIX System that combines the intramyocardial delivery of stem cells with transmyocardial revascularization (TMR).
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.
› Verified 5 days ago
| Entity Name | Advanced Rehabilitation Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285942722 PECOS PAC ID: 8628253259 Enrollment ID: O20110426000464 |
News Archive
While depression appears to be common in early Parkinson's disease (PD), it is often not treated or diagnosed, according to newly released research.
New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic.
Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study. Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company's proprietary PHOENIX System that combines the intramyocardial delivery of stem cells with transmyocardial revascularization (TMR).
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Cohon Shaikh, MD 2500 W Higgins Rd Ste 1165, Hoffman Estates, IL 60169-2050 Ph: (847) 289-5727 | Laura Cohon Shaikh, MD 77 N Airlite St, Elgin, IL 60123-4912 Ph: (847) 289-5727 |
News Archive
While depression appears to be common in early Parkinson's disease (PD), it is often not treated or diagnosed, according to newly released research.
New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic.
Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study. Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company's proprietary PHOENIX System that combines the intramyocardial delivery of stem cells with transmyocardial revascularization (TMR).
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.
› Verified 5 days ago
Merrie Viscarra, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1530 N Randall Rd Ste 210, Elgin, IL 60123 Phone: 224-760-7322 Fax: 224-535-8252 | |
Lynn Rae Mershon, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1990 Larkin Ave, Suite 3, Elgin, IL 60123 Phone: 847-289-5727 Fax: 847-888-5469 | |
Susan Eileen Zuckerman, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1975 Lin Lor Ln, Suite 195, Elgin, IL 60123 Phone: 847-468-1511 Fax: 847-468-1555 | |
Dr. Anthony Paul Lebario, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 431 Summit St, Elgin, IL 60120 Phone: 847-289-8822 | |
Dr. Michelle Pamplona Tabao, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1975 Lin Lor Ln, Suite 195, Elgin, IL 60123 Phone: 847-468-1511 Fax: 847-468-1555 | |
James H Cohn, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1990 Larkin Ave, Suite 3, Elgin, IL 60123 Phone: 847-289-5727 Fax: 847-888-5469 | |
Gary Michael Yarkony, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1975 Lin Lor Ln, Suite 195, Elgin, IL 60123 Phone: 847-468-1511 |